Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Johnson and Johnson
Pharmaceuticals
Blood Cancer
JPMorgan Chase
Lego
Apple
Verizon
Moderna
Nike
Ford Motor
Walmart
Chevron
Topics

Advertisement

Johnson and Johnson

Share

Top Latest Popular

Yesterday

J&J Units Target Alvotech Simponi Biosimilars in New Patent Suit Bloomberg Law 17:28 Mon, 22 Jun

The Zacks Analyst Blog Highlights Alphabet, Broadcom, Johnson & Johnson, Franklin and Park Aerospace Zacks 10:59 Mon, 22 Jun

Friday

Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm The Motley Fool 18:26 Fri, 19 Jun

Advertisement

Advertisement

Johnson & Johnson (JNJ) Could Be a Great Choice Zacks 17:52 Fri, 19 Jun

Thursday

Top Research Reports for Alphabet, Broadcom & Johnson & Johnson Zacks 23:18 Thu, 18 Jun

Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight PR Newswire (Press Release) 17:38 Thu, 18 Jun

STAT Plus: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more STAT 14:34 Thu, 18 Jun

J&J Can't Get New Trial In $65.5M Minn. Talc Cancer Case Law360 01:28 Thu, 18 Jun

Wednesday

J&J Takes a Pass on Obesity Drugs to Focus Efforts on Cancer Bloomberg Law 16:28 Wed, 17 Jun

Notable ETF Inflow Detected - JGRO, JNJ, MA, WMT Nasdaq 16:12 Wed, 17 Jun

Critical Mass With Law.com's Amanda Bronstad: Judge in $4B Sex Abuse Settlement Probes Lawyers Over Possible Fraud, LA Juries Hit J&J With $32M Talc Verdict and a Mistrial Law.com 16:03 Wed, 17 Jun

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know Zacks 15:02 Wed, 17 Jun

In the last month

J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case Law360 23:59 Tue, 16 Jun

J&J Talc Trial In LA Ends With Deadlocked Jury Law360 22:58 Tue, 16 Jun

EHA26: J&J’s multiple myeloma therapies impress with new data Pharmaceutical Technology 18:01 Tue, 16 Jun

J&J Wants Talc MDL Tossed After Plaintiffs Withdraw Experts Law360 23:03 Mon, 15 Jun

Johnson & Johnson pumping $1B into First Coast manufacturing facility Florida Politics 21:28 Mon, 15 Jun

Advertisement

J&J outlays $1bn to strengthen Floridian contact lens manufacturing provision Verdict Medical Devices 18:09 Mon, 15 Jun

J&J multiple myeloma drug gains edge in earlier stage disease BioPharma Dive 18:01 Mon, 15 Jun

Merck, Bristol Slip on Risk From Proposed CMS Rule, RBC Says Bloomberg Law 17:54 Mon, 15 Jun

How Investors Are Reacting To Johnson & Johnson (JNJ) Multiple Myeloma Trial Data For TALVEY Combinations Simply Wall St 15:58 Mon, 15 Jun

Johnson & Johnson Commits Over $1 Billion To Expand U.S. Vision Manufacturing RTT News 14:46 Mon, 15 Jun

Johnson & Johnson To Strengthen Vision Operations In Jacksonville RTT News 11:53 Mon, 15 Jun

Data could move J&J's Talvey earlier in myeloma therapy pharmaphorum 11:21 Mon, 15 Jun

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida Business Wire (Press Release) 11:05 Mon, 15 Jun

New Talvey® (talquetamab-tgvs) plus Darzalex Faspro® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma PR Newswire (Press Release) 11:38 Sat, 13 Jun

J&J Trial Over Doctor's Cancer Death Ends In Settlement Law360 01:29 Sat, 13 Jun

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts Zacks 23:51 Fri, 12 Jun

J&J poster puts Spravato remission data at center of treatment-resistant-depression growth push Drug Discovery & Development 22:55 Fri, 12 Jun

J&J Moves to Shed Cases Claiming Talc Products Caused Cancer Bloomberg Law 21:35 Fri, 12 Jun

Johnson & Johnson Just Paid $1 Billion for a Technology That Could Crack One of Cancer's Most "Undruggable" Targets. Why That's Very Good News for Investors. The Motley Fool 19:35 Fri, 12 Jun

J&J reports data from Phase II/III ENERGY trial for wAIHA Clinical Trials Arena 16:04 Fri, 12 Jun

J&J Expands U.S. Availability Of Tecnis PureSee Iol For Cataract Patients RTT News 14:36 Thu, 11 Jun

J&J adds rare disease wAIHA to Imaavy's potential uses pharmaphorum 14:05 Thu, 11 Jun

Johnson & Johnson Expands U.S. Availability of Tecnis PureSee Iol, an Advanced Lens Option for Cataract Surgeons and Patients Business Wire (Press Release) 12:45 Thu, 11 Jun

England: Group litigation order approved in Johnson & Johnson baby powder case Scottish Legal News 11:00 Thu, 11 Jun

Johnson & Johnson's Imaavy Shows Rapid And Durable Hemoglobin Improvements In Pivotal Waiha Study RTT News 10:22 Thu, 11 Jun

Johnson & Johnson will acquire Firefly Bio, betting $1 billion on cancer treatment The State, South Carolina 21:20 Wed, 10 Jun

Noteworthy Wednesday Option Activity: LLY, JNJ, CASY Nasdaq 19:39 Wed, 10 Jun

Johnson & Johnson Hit with $32 Million Verdict in Los Angeles Asbestos Trial Business Wire (Press Release) 16:23 Wed, 10 Jun

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis